IOL Chemicals & Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 532.18 | 509.76 | 511.44 |
| Operating Expense | 484.19 | 451.58 | 453.84 |
| Net Profit | 19.15 | 29.68 | 28.19 |
| Net Profit Margin | 3.60 | 5.82 | 5.51 |
| Earning Per Share | 3.26 | 5.06 | 4.80 |
| EBIDTA | 45.77 | 57.40 | 53.04 |
| Effective Tax Rate | 9.52 | 15.07 | 8.72 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 532.18 |
| Operating Expense | 484.19 |
| Net Profit | 19.15 |
| Net Profit Margin | 3.60 |
| Earning Per Share | 3.26 |
| EBIDTA | 45.77 |
| Effective Tax Rate | 9.52 |
Invest in IOL Chemicals & Pharmaceuticals Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 2,132.79 | 2,217.11 | 2,184.02 |
| Operating Expenses Annual | 1,901.27 | 1,990.59 | 1,927.74 |
| Operating Profit Annual | 261.59 | 252.09 | 274.39 |
| Interest Annual | 16.10 | 16.47 | 8.29 |
| Depreciation | 62.85 | 46.13 | 43.26 |
| Net Profit Annual | 135.42 | 139.98 | 165.66 |
| Tax Annual | 47.22 | 49.51 | 57.18 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 2,132.79 |
| Operating Expenses Annual | 1,901.27 |
| Operating Profit Annual | 261.59 |
| Interest Annual | 16.10 |
| Depreciation | 62.85 |
| Net Profit Annual | 135.42 |
| Tax Annual | 47.22 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.96 | 1.12 | 32.34 |
| Cash Flow from Operations | 290.76 | 123.14 | 91.04 |
| Cash Flow from Investing | -191.69 | -119.19 | -120.62 |
| Cash Flow from Financing | -92.50 | -4.11 | -1.64 |
| Cash Flow at the End | 7.53 | 0.96 | 1.12 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.96 |
| Cash Flow from Operations | 290.76 |
| Cash Flow from Investing | -191.69 |
| Cash Flow from Financing | -92.50 |
| Cash Flow at the End | 7.53 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 12.27 | 11.37 | 12.56 |
| PBIT Margin (%) | 9.32 | 9.29 | 10.58 |
| PBT Margin (%) | 8.74 | 8.73 | 9.30 |
| Net PROFIT Margin (%) | 6.35 | 6.31 | 7.59 |
| Return On Networth / Equity (%) | 8.69 | 9.66 | 12.50 |
| Return On Networth /Employed (%) | 12.27 | 13.61 | 17.09 |
| Return On Assets (%) | 8.38 | 9.28 | 12.21 |
| Total Debt / Equity (X) | 0.04 | 0.04 | 0.02 |
| Asset Turnover Ratio (%) | 1.32 | 1.47 | 1.61 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 12.27 |
| PBIT Margin (%) | 9.32 |
| PBT Margin (%) | 8.74 |
| Net PROFIT Margin (%) | 6.35 |
| Return On Networth / Equity (%) | 8.69 |
| Return On Networth /Employed (%) | 12.27 |
| Return On Assets (%) | 8.38 |
| Total Debt / Equity (X) | 0.04 |
| Asset Turnover Ratio (%) | 1.32 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 933.73 | 759.55 | 563.81 |
| Total Current Assets Annual | 1,119.48 | 919.07 | 1,078.71 |
| Non Current Assets Annual | 1,124.49 | 1,101.54 | 881.58 |
| Total Shareholders Funds Annual | 1,611.33 | 1,506.55 | 1,390.27 |
| Total Assets Annual | 2,243.97 | 2,020.61 | 1,960.29 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 933.73 |
| Total Current Assets Annual | 1,119.48 |
| Non Current Assets Annual | 1,124.49 |
| Total Shareholders Funds Annual | 1,611.33 |
| Total Assets Annual | 2,243.97 |
EPS (INR)
Expected
3.26
Reported
3.26
Surprise
0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.20%
Dec 2023
EPS beaten by 0.21%
